Officer of Vor Biopharma Inc. (NASDAQ:VOR), recently sold shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The transaction, which occurred on ...
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat Ratings ...
Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...